Zonal Market Access Manager
No salary listed
Senior, Expert
Bachelor's, Master's, MBA
Kolkata, West Bengal, India
In PersonRegular travel to state capitals and key cities, with occasional travel to national headquarters.
Business & Strategy
About the job
Requirements
- A bachelor's degree in pharmacy, life sciences, business, public health, or a related field.
- Eight to ten years of pharmaceutical or healthcare industry experience.
- A proven track record in state-level stakeholder engagement, with examples of state or central interim funding or reduced timelines to formulary listing or regional centers.
- Experience managing access programs and payer negotiations for specialty or innovative therapies.
- Understanding of Indian state healthcare systems and approaches to innovative therapy access.
- Experience in market access, government affairs, or payer relations is a plus.
- Ability to navigate complex state bureaucracies.
- Cultural sensitivity to regional differences.
Responsibilities
- Identify, analyze, and pursue state and central government funding opportunities for specialty therapies, including Rare Disease treatments, Qfitlia, Rezurock, and the Transplant portfolio.
- Build relationships with state health departments and finance ministries to secure funding for the specialty portfolio.
- Develop and implement funding proposals for state health departments and finance ministries that demonstrate clinical value and economic benefits.
- Navigate state health schemes and budget allocation processes to secure sustainable funding pathways for specialized therapies.
- Lead evidence-based advocacy initiatives to include the company's portfolio in state essential medicine lists and formularies.
- Monitor healthcare budget cycles to optimize the timing of funding requests and proposals.
- Lead engagement with state insurance schemes and regional payers, communicating the value proposition of current and future specialty therapies.
- Co-create access value dossiers with cross-functional and global-local access teams, tailored to regional needs and emphasizing clinical and economic benefits.
- Drive product inclusion in regional institution formularies and accelerate access to breakthrough treatments.
- Track payer policy developments and incorporate insights into regional access plans to accelerate formulary listings and support value propositions.
- Replicate successful state advocacy approaches across states.
- Build relationships with state health officials and commissioners to advocate for innovative immunology treatments.
- Collaborate with public health organizations to address unmet needs in immunology.
- Execute regional market access plans aligned with national strategy for Rare Disease interim funding, Rezurock, Qfitlia, and future specialty pipeline products.
- Translate national objectives into actionable regional plans and provide regional insights to inform national strategy for the immunology portfolio.
- Support national policy advocacy focused on access to innovative treatments.
- Represent the company at regional healthcare forums, policy discussions, and industry events.
- Partner with regional sales teams to gather market intelligence on the immunology treatment landscape.
- Collaborate with medical affairs on regional key opinion leader engagement.
- Work with marketing on regional campaigns highlighting treatments.
- Coordinate with supply chain on product availability and future launches.
Desired Qualifications
- An MBA or master's degree in healthcare management or public health.
- An advanced degree in health economics or public policy.
- Multi-state or regional experience across India.
- Knowledge of state funding and formulary listing processes for specialty medicines.
- Experience designing patient support programs for innovative therapies.
- Understanding of regional insurance schemes and their approach to breakthrough treatments.
- Regional language skills.
About the company
Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.
Company Size
10,001+
Company Stage
IPO
Headquarters
Paris, France
Founded
1973
Get referred to Sanofi
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
- June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
- Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.
What critics are saying
- Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
- Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
- Dupixent concentration makes 2030s patent loss an existential revenue shock.
What makes Sanofi unique
- Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
- October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
- Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Professional Development Budget
- Parental Leave